Klaas Poelstra - Search Results

Year	Number of Results
2002	3
2003	5
2004	5
2005	6
2006	11
2007	10
2008	4
2009	2
2010	5
2011	9
2012	5
2013	2
2014	6
2015	3
2016	3
2017	3
2018	1
2019	1
2020	3
2021	1
2022	1
2023	2
2024	1

1

The role of intestinal alkaline phosphatase in the development of necrotizing enterocolitis.

Martins RDS, Kooi EMW, Poelstra K, Hulscher JBF. Martins RDS, et al. Among authors: poelstra k. Early Hum Dev. 2023 Aug;183:105797. doi: 10.1016/j.earlhumdev.2023.105797. Epub 2023 Jun 7. Early Hum Dev. 2023. PMID: 37300991 Review.

2

Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation.

Salvati A, Poelstra K. Salvati A, et al. Among authors: poelstra k. Pharmaceutics. 2022 Jan 17;14(1):217. doi: 10.3390/pharmaceutics14010217. Pharmaceutics. 2022. PMID: 35057111 Free PMC article. Review.

3

Liver fibrosis in 2015: Crucial steps towards an effective treatment.

Poelstra K. Poelstra K. Nat Rev Gastroenterol Hepatol. 2016 Feb;13(2):67-8. doi: 10.1038/nrgastro.2015.224. Epub 2016 Jan 13. Nat Rev Gastroenterol Hepatol. 2016. PMID: 26758787 Review. No abstract available.

4

Hepatic Stellate Cell Targeting Using Peptide-Modified Biologicals.

Bansal R, Poelstra K. Bansal R, et al. Among authors: poelstra k. Methods Mol Biol. 2023;2669:269-284. doi: 10.1007/978-1-0716-3207-9_17. Methods Mol Biol. 2023. PMID: 37247067

5

Drug targeting to the diseased liver.

Poelstra K, Prakash J, Beljaars L. Poelstra K, et al. J Control Release. 2012 Jul 20;161(2):188-97. doi: 10.1016/j.jconrel.2012.02.011. Epub 2012 Feb 17. J Control Release. 2012. PMID: 22370583 Review.

6

Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis.

Beljaars L, Meijer DK, Poelstra K. Beljaars L, et al. Among authors: poelstra k. Front Biosci. 2002 May 1;7:e214-22. doi: 10.2741/A917. Front Biosci. 2002. PMID: 11991830 Review.

7

Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.

Deshmukh M, Nakagawa S, Higashi T, Vincek A, Venkatesh A, Ruiz de Galarreta M, Koh AP, Goossens N, Hirschfield H, Bian CB, Fujiwara N, Ono A, Hoshida H, El-Abtah M, Ahmad NB, Lujambio A, Sanchez R, Fuchs BC, Poelstra K, Prakash J, Hoshida Y; Precision Liver Cancer Prevention Consortium. Deshmukh M, et al. Among authors: poelstra k. Nanomedicine. 2018 Feb;14(2):317-325. doi: 10.1016/j.nano.2017.11.004. Epub 2017 Nov 20. Nanomedicine. 2018. PMID: 29157977 Free PMC article.

8

WNT-5A regulates TGF-β-related activities in liver fibrosis.

Beljaars L, Daliri S, Dijkhuizen C, Poelstra K, Gosens R. Beljaars L, et al. Among authors: poelstra k. Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G219-G227. doi: 10.1152/ajpgi.00160.2016. Epub 2017 Jan 5. Am J Physiol Gastrointest Liver Physiol. 2017. PMID: 28057611 Free article.

9

Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma.

van Dijk F, Olinga P, Poelstra K, Beljaars L. van Dijk F, et al. Among authors: poelstra k. Front Med (Lausanne). 2015 Oct 5;2:72. doi: 10.3389/fmed.2015.00072. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26501061 Free PMC article. Review.

10

Specific delivery of kinase inhibitors in nonmalignant and malignant diseases.

van Beuge MM, Poelstra K, Prakash J. van Beuge MM, et al. Among authors: poelstra k. Expert Opin Drug Deliv. 2012 Jan;9(1):59-70. doi: 10.1517/17425247.2012.638625. Epub 2011 Nov 23. Expert Opin Drug Deliv. 2012. PMID: 22111941 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

85 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year